Cristin Rothfuss
Förmögenhet: 2 M $ per 2026-09-30
Förmögenhet: 2 M $ per 2026-09-30
Cristin L.
Rothfuss is Executive Vice President & General Counsel at Sarepta Therapeutics, Inc. since 2026.
Formerly worked as Senior Associate Director at the Office of Technology Development.
Educated at Yale University (undergraduate) and Connecticut School of Law University Of (graduate).
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-09-04 | 115 519 ( 0,11 % ) | 2 M $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Generell Rådgivare | 2021-02-01 |
| Företag | Position | Slut |
|---|---|---|
Office of Technology Development
Office of Technology Development Investment ManagersFinance Office of Technology Development invests in companies located in the United States. The firm focuses on health and technology sectors. It participates in early-stage transactions. | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Office of Technology Development
Office of Technology Development Investment ManagersFinance Office of Technology Development invests in companies located in the United States. The firm focuses on health and technology sectors. It participates in early-stage transactions. | Finance |
Connecticut School of Law University Of
Connecticut School of Law University Of Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån